Exact Sciences is a pioneering biotechnology company focused on developing innovative solutions for cancer detection, particularly colorectal cancer. The company's flagship product, Cologuard®, is an FDA-approved, noninvasive multi-target stool DNA test designed for colorectal cancer screening in adults aged 50 to 84. Cologuard offers impressive performance metrics, with a 92% sensitivity for detecting colorectal cancers compared to 74% for traditional fecal immunochemical tests, making it a vital tool for early detection.

Exact Sciences Laboratories prides itself on delivering accurate results and exceptional service to both physicians and patients, emphasizing quality, compliance, and patient privacy. They offer comprehensive lab client services, including access to a secure provider portal—EpicCare Link—where healthcare professionals can manage patient orders and access test results. With a commitment to improving cancer screening and ensuring peace of mind, Exact Sciences continues to set the standard in diagnostic innovation, serving as a reliable partner in colorectal cancer prevention and care